Institutional members access full text with Ovid®

Share this article on:

Ondansetron (Zofran) Warning Strengthened

Aschenbrenner, Diane S. MS, RN

AJN The American Journal of Nursing: January 2012 - Volume 112 - Issue 1 - p 24
doi: 10.1097/01.NAJ.0000410355.34028.8a
Drug Watch

Diane S. Aschenbrenner is the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch:

© 2012 Lippincott Williams & Wilkins, Inc.